Overview:
Glaucoma surgeries are ophthalmic procedures designed to reduce intraocular pressure (IOP) and prevent progressive damage to the optic nerve caused by glaucoma. Glaucoma is a group of eye conditions, often associated with elevated eye pressure, that can lead to irreversible vision loss if untreated. When medications or laser treatments fail to control IOP adequately, surgical interventions are considered. Common procedures include trabeculectomy, glaucoma drainage devices (tube shunts), minimally invasive glaucoma surgery (MIGS), and laser-based treatments. These procedures aim to improve fluid drainage from the eye or reduce fluid production, thereby protecting vision.

What to Expect:

• Symptoms Leading to Surgery:
  Patients may experience gradual loss of peripheral vision, tunnel vision in advanced stages, eye pain, blurred vision, halos around lights, or increased eye pressure detected during routine examinations. Many cases are asymptomatic until late stages, making regular screenings crucial.
• Diagnosis:
  Ophthalmologists diagnose glaucoma using comprehensive eye exams including tonometry (to measure IOP), visual field testing, optical coherence tomography (OCT) for optic nerve assessment, gonioscopy (to examine the drainage angle), and slit-lamp examination. If disease progression persists despite medications, surgery is recommended.
• Treatment (Surgical Procedures):
  • Trabeculectomy: Creates a drainage channel in the sclera for aqueous fluid to exit, lowering eye pressure.
  • Glaucoma Drainage Implants: Small tubes are inserted to divert fluid to a reservoir, reducing IOP.
  • Minimally Invasive Glaucoma Surgery (MIGS): Uses micro-stents or devices to enhance drainage with faster recovery.
  • Laser Procedures (e.g., cyclophotocoagulation): Target ciliary body tissue to reduce fluid production.
    Surgeries are performed under local or general anesthesia, often as outpatient procedures, with follow-up needed to monitor healing and IOP.

What to Consider:

• Risk Factors: Age over 40, family history of glaucoma, diabetes, hypertension, thin corneas, previous eye injuries, and steroid use increase glaucoma risk. Patients unresponsive to eye drops or laser therapy are candidates for surgery.
• Prevention: Glaucoma cannot always be prevented, but early detection through regular eye exams is key to preserving vision. Adherence to treatment and monitoring can delay or avoid the need for surgery.
• Progression: Untreated glaucoma can cause irreversible optic nerve damage, leading to gradual and permanent blindness. Surgical intervention slows or halts progression but does not restore lost vision.

Other Information:

• Complications: Potential risks include infection, bleeding, cataract formation, scarring of the drainage site, excessively low eye pressure (hypotony), or vision fluctuations. MIGS procedures generally carry lower complication rates than traditional surgery.
• Prognosis: Success rates are high, with many patients achieving significant and lasting IOP reduction. Lifelong follow-up is required, as glaucoma remains a chronic condition even after surgery.

Conclusion:
Glaucoma surgeries provide effective long-term solutions for controlling intraocular pressure in patients who do not respond adequately to medications or laser therapies. While they cannot cure glaucoma or reverse existing vision loss, they are vital in preventing further damage to the optic nerve and preserving remaining sight. With advances in minimally invasive techniques, modern glaucoma surgery offers safer, more precise, and patient-friendly options for managing this vision-threatening disease.

‍